Catalyst Pharmaceuticals Inc. (CPRX)

Catalyst Pharmaceuticals Inc. (CPRX $28.09)
- $28.09 P/E (TTM): 17.42X Cap: $3.45B
- View CPRX Profile
- View Questions on CPRX

{tplLang.businessdescription | toLang tLang}

{ profileData.description }

{tplLang.details | toLang tLang}

{tplLang.ceo | toLang tLang}

{profileData.profile.details.ceo}

{tplLang.employees | toLang tLang}

{profileData.profile.details.employees | numeraljs '0,0'}

{tplLang.issuetype | toLang tLang}

{profileData.profile.details.issuetype | asIssueType}

{tplLang.industryclassifications | toLang tLang}

{tplLang.sector | toLang tLang}

{profileData.profile.classification.sector}

{tplLang.industry | toLang tLang}

{profileData.profile.classification.industry}

{tplLang.toolname| toLang tLang}

There is no {tplLang.toolname| toLang tLang} currently available for {data.symbolstring}.

Intuitive Surgical Inc. (ISRG $455.44)
- $455.44 P/E (TTM): 56.7X Cap: $160.72B
- View ISRG Profile
- View Questions on ISRG
Vertex Pharmaceuticals Incorporated (VRTX $430.12)
- $430.12 P/E (TTM): 28.13X Cap: $107.69B
- View VRTX Profile
- View Questions on VRTX
AbbVie Inc. (ABBV $213.01)
- $213.01 P/E (TTM): 83.77X Cap: $360.63B
- View ABBV Profile
- View Questions on ABBV
Johnson & Johnson (JNJ $230.23)
- $230.23 P/E (TTM): 20.65X Cap: $547.28B
- View JNJ Profile
- View Questions on JNJ
Eli Lilly and Company (LLY $935.53)
- $935.53 P/E (TTM): 38.08X Cap: $804.23B
- View LLY Profile
- View Questions on LLY
Merck & Company Inc. (MRK $110.89)
- $110.89 P/E (TTM): 15.11X Cap: $274.18B
- View MRK Profile
- View Questions on MRK
iShares Biotechnology ETF (IBB $168.69)
- $168.69 P/E (TTM): 23.15X Cap: $7.97B
- View IBB Profile
- View Questions on IBB
IDEXX Laboratories Inc. (IDXX $560.00)
- $560.00 P/E (TTM): 43.45X Cap: $44.02B
- View IDXX Profile
- View Questions on IDXX
Halozyme Therapeutics Inc. (HALO $64.05)
- $64.05 P/E (TTM): 25.24X Cap: $7.47B
- View HALO Profile
- View Questions on HALO
Incyte Corporation (INCY $98.57)
- $98.57 P/E (TTM): 15.25X Cap: $19.79B
- View INCY Profile
- View Questions on INCY
Catalyst Pharmaceuticals Inc. (CPRX $28.09)
- $28.09 P/E (TTM): 17.42X Cap: $3.45B
- View CPRX Profile
- View Questions on CPRX
Gilead Sciences CDR (CAD Hedged) (GILD $26.82)
- $26.82 P/E (TTM): 19.06X Cap: $221.78B
- View GILD Profile
- View Questions on GILD

Q: We have accumulated 11 healthcare stocks and 1 ETF, While LLY and ISRG are at half positions the rest are at initial 25% positions. Please advise [help!] us get to a more concentrated portfolio with a 3+ year horizon for reasonable opportunities in healthcare

Read Answer Asked by sam on January 13, 2026

AbbVie Inc. (ABBV $213.01)
- $213.01 P/E (TTM): 83.77X Cap: $360.63B
- View ABBV Profile
- View Questions on ABBV
Eli Lilly and Company (LLY $935.53)
- $935.53 P/E (TTM): 38.08X Cap: $804.23B
- View LLY Profile
- View Questions on LLY
Cipher Pharmaceuticals Inc. (CPH $17.85)
- $17.85 P/E (TTM): 12.58X Cap: $457M
- View CPH Profile
- View Questions on CPH
- View Reports on CPH
Halozyme Therapeutics Inc. (HALO $64.05)
- $64.05 P/E (TTM): 25.24X Cap: $7.47B
- View HALO Profile
- View Questions on HALO
uniQure N.V. (QURE $20.03)
- $20.03 Cap: $1.12B
- View QURE Profile
- View Questions on QURE
Catalyst Pharmaceuticals Inc. (CPRX $28.09)
- $28.09 P/E (TTM): 17.42X Cap: $3.45B
- View CPRX Profile
- View Questions on CPRX

Q: Hi, could you suggest a couple each of your fav. small, mid and large cap biotech stocks and why you like them.

thanks, M

Read Answer Asked by Mark on October 08, 2025

Catalyst Pharmaceuticals Inc. (CPRX $28.09)
- $28.09 P/E (TTM): 17.42X Cap: $3.45B
- View CPRX Profile
- View Questions on CPRX
Elevance Health Inc. (ELV $374.41)
- $374.41 P/E (TTM): 15.44X Cap: $81.78B
- View ELV Profile
- View Questions on ELV

Q: What's your opinion about these two stocks? Buy/Hold/Sell? Timeframe: 3-5 years. Risk tolerance: moderate.

Read Answer Asked by Paul on September 12, 2025